Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| XERS | McCulloch Kevin | See Remarks | 11/05/2026 | Verkauf | 12.49 | 25,000 | 312,215 | Form 4 |
| XERS | Pieper Steven | See Remarks | 11/02/2026 | Verkauf | 10.23 | 5,000 | 51,174 | Form 4 |
| XERS | Hecht Beth | See Remarks | 11/02/2026 | Verkauf | 10.23 | 25,000 | 255,828 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 11/02/2026 | Verkauf | 10.23 | 15,000 | 153,488 | Form 4 |
| XERS | Pieper Steven | See Remarks | 10/01/2026 | Verkauf | 9.41 | 5,000 | 47,037 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 10/01/2026 | Verkauf | 9.41 | 15,000 | 141,120 | Form 4 |
| XERS | Hecht Beth | See Remarks | 10/01/2026 | Verkauf | 9.41 | 16,666 | 156,792 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 09/28/2026 | Verkauf | 10.00 | 25,000 | 250,000 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 09/01/2026 | Verkauf | 8.49 | 15,000 | 127,308 | Form 4 |
| XERS | Pieper Steven | See Remarks | 09/01/2026 | Verkauf | 8.50 | 5,000 | 42,500 | Form 4 |
| XERS | Hecht Beth | See Remarks | 09/01/2026 | Verkauf | 8.49 | 16,666 | 141,434 | Form 4 |
| XENE | Kenney Christopher John | Chief Medical Officer | 08/28/2026 | Verkauf | 60.98 | 700 | 42,684 | Form 4 |
| XENE | Kenney Christopher John | Chief Medical Officer | 08/28/2026 | Verkauf | 60.17 | 6,368 | 383,145 | Form 4 |
| XERS | Pieper Steven | See Remarks | 08/12/2026 | Verkauf | 8.50 | 5,000 | 42,500 | Form 4 |
| XENE | Gannon Steven | Director | 08/11/2026 | Verkauf | 64.06 | 10,000 | 640,550 | Form 4 |
| XERS | McCulloch Kevin | See Remarks | 08/03/2026 | Verkauf | 8.02 | 15,000 | 120,240 | Form 4 |
| XERS | Hecht Beth | See Remarks | 08/03/2026 | Verkauf | 8.01 | 16,666 | 133,553 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).